Saturday, October 31, 2026

Astrazeneca And 5 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

November 8, 2021

Astrazeneca And 5 Other Stocks Have Very High Payout Ratio

(VIANEWS) - NRG Energy (NRG), Astrazeneca (AZN), Companhia Brasileira de Distribuicao ADS (CBD) are the highest payout ratio stocks on this list.

We have collected information about stocks with the highest payout ratio up until now. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. NRG Energy (NRG)

98% Payout Ratio

NRG Energy, Inc., together with its subsidiaries, operates as an energy company in the United States.

Volume

Today's last reported volume for NRG Energy is 1563780, 24.06% below its average volume of 2059350.

As maintained by Morningstar, Inc., the next dividend payment is on Apr 29, 2021, the estimated forward annual dividend rate is 1.3 and the estimated forward annual dividend yield is 3.53%.

NRG Energy's sales growth this year is anticipated to be 119.5% and a negative 22.1% for next year.

Year-on-year quarterly revenue growth grew by 300.7%, now sitting on 15.16B for the twelve trailing months.

NRG Energy's sales growth for the next quarter is 83%. The company's growth estimates for the present quarter and the next is 126.5% and negative -29.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.11%.

Volatility

NRG Energy's last day, week, and month's current volatility was 2.02%, 3.89%, and 1.75%, respectively.

NRG Energy's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.87% (day), 3.98% (last week), and 2.51% (last month), respectively.

NRG Energy's Stock Yearly Top and Bottom Value

NRG Energy's stock is valued at $35.11 at 13:23 EST, way below its 52-week high of $46.10 and way above its 52-week low of $30.47.

NRG Energy's Moving Average

NRG Energy's worth is way under its 50-day moving average of $40.85 and way under its 200-day moving average of $39.74.

Previous days news about NRG Energy (NRG)

  • According to Bloomberg Quint on Thursday, 4 November, "Independent power producer NRG Energy Inc. expects earnings to slip next year due to "unprecedented" supply-chain constraints and mounting coal costs."

2. Astrazeneca (AZN)

97.56% Payout Ratio

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.

Volume

Today's last reported volume for Astrazeneca is 2484810, 53.32% below its average volume of 5324060.

As maintained by Morningstar, Inc., the next dividend payment is on Aug 11, 2021, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 2.39%.

Astrazeneca's sales growth this year is expected to be 35.1% and 15.7% for next year.

Year-on-year quarterly revenue growth grew by 31%, now sitting on 29.53B for the twelve trailing months.

Astrazeneca's sales growth is 51.8% for the present quarter and 43% for the next. The company's growth estimates for the current quarter and the next is 40.4% and 45.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.67%.

Volatility

Astrazeneca's last day, week, and month's current volatility was 1.17%, 0.70%, and 0.77%, respectively.

Astrazeneca's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.46% (day), 1.38% (last week), and 1.19% (last month), respectively.

Astrazeneca's Stock Yearly Top and Bottom Value

Astrazeneca's stock is valued at $63.17 at 13:23 EST, under its 52-week high of $64.21 and way higher than its 52-week low of $46.48.

Astrazeneca's Moving Average

Astrazeneca's worth is higher than its 50-day moving average of $60.71 and above its 200-day moving average of $58.06.

Previous days news about Astrazeneca (AZN)

  • According to Bloomberg Quint on Thursday, 4 November, "Intense pricing pressure in the U.S. hit Strides Pharma Ltd., while lower profitability impacted Astrazeneca Pharma."

3. Companhia Brasileira de Distribuicao ADS (CBD)

45.28% Payout Ratio

Volume

Today's last reported volume for Companhia Brasileira de Distribuicao ADS is 1411300, 35.47% above its average volume of 1041770.

As claimed by Morningstar, Inc., the next dividend payment is on May 5, 2021, the estimated forward annual dividend rate is 0.43 and the estimated forward annual dividend yield is 9.79%.

Companhia Brasileira de Distribuicao ADS's sales growth this year is anticipated to be negative 4.3% and a negative 16% for next year.

Year-on-year quarterly revenue growth declined by 5.3%, now sitting on 51.16B for the twelve trailing months.

The company's growth estimates for the present quarter and the next is negative 93.3% and negative -145.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.58%.

Volatility

Companhia Brasileira de Distribuicao ADS's last day, week, and month's current volatility was 1.13%, 1.30%, and 3.20%, respectively.

Companhia Brasileira de Distribuicao ADS's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.78% (day), 3.96% (last week), and 4.56% (last month), respectively.

Companhia Brasileira de Distribuicao ADS's Stock Yearly Top and Bottom Value

Companhia Brasileira de Distribuicao ADS's stock is valued at $4.47 at 13:23 EST, way below its 52-week high of $17.46 and way above its 52-week low of $3.82.

Companhia Brasileira de Distribuicao ADS's Moving Average

Companhia Brasileira de Distribuicao ADS's worth is under its 50-day moving average of $4.85 and way under its 200-day moving average of $6.27.

4. Nuveen Select Maturities Municipal Fund (NIM)

45.07% Payout Ratio

Nuveen Select Maturities Municipal Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC.

Volume

Today's last reported volume for Nuveen Select Maturities Municipal Fund is 9293, 40.86% below its average volume of 15715.

As maintained by Morningstar, Inc., the next dividend payment is on Jul 13, 2021, the estimated forward annual dividend rate is 0.29 and the estimated forward annual dividend yield is 2.64%.

Year-on-year quarterly revenue growth declined by 5.4%, now sitting on 4.34M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.61%.

Volatility

Nuveen Select Maturities Municipal Fund's last day, week, and month's current volatility was 0.09%, 0.19%, and 0.39%, respectively.

Nuveen Select Maturities Municipal Fund's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.38% (day), 0.74% (last week), and 0.81% (last month), respectively.

Nuveen Select Maturities Municipal Fund's Stock Yearly Top and Bottom Value

Nuveen Select Maturities Municipal Fund's stock is valued at $10.64 at 13:23 EST, below its 52-week high of $11.30 and higher than its 52-week low of $10.19.

Nuveen Select Maturities Municipal Fund's Moving Average

Nuveen Select Maturities Municipal Fund's value is below its 50-day moving average of $10.68 and under its 200-day moving average of $10.80.

5. Western Asset High Income Opportunity Fund (HIO)

35.75% Payout Ratio

Western Asset High Income Opportunity Fund Inc. is a closed ended fixed-income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC.

Volume

Today's last reported volume for Western Asset High Income Opportunity Fund is 205481, 18.56% above its average volume of 173307.

As stated by Morningstar, Inc., the next dividend payment is on Nov 18, 2021, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 6.88%.

Year-on-year quarterly revenue growth declined by 27%, now sitting on 42.49M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.44%.

Volatility

Western Asset High Income Opportunity Fund's last day, week, and month's current volatility was 0.19%, 0.27%, and 0.36%, respectively.

Western Asset High Income Opportunity Fund's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.15% (day), 0.81% (last week), and 0.79% (last month), respectively.

Western Asset High Income Opportunity Fund's Stock Yearly Top and Bottom Value

Western Asset High Income Opportunity Fund's stock is valued at $5.24 at 13:23 EST, under its 52-week high of $5.39 and higher than its 52-week low of $4.88.

Western Asset High Income Opportunity Fund's Moving Average

Western Asset High Income Opportunity Fund's value is above its 50-day moving average of $5.23 and higher than its 200-day moving average of $5.22.

6. Prudential Bancorp (PBIP)

34.57% Payout Ratio

Prudential Bancorp, Inc. operates as the bank holding company for Prudential Bank that provides various banking products or services.

Volume

Today's last reported volume for Prudential Bancorp is 2133, 75.22% below its average volume of 8610.

According to Morningstar, Inc., the next dividend payment is on Sep 2, 2021, the estimated forward annual dividend rate is 0.28 and the estimated forward annual dividend yield is 1.95%.

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 24.25M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.88%.

Volatility

Prudential Bancorp's last day, week, and month's current volatility was 0.75%, 0.62%, and 0.71%, respectively.

Prudential Bancorp's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.36% (day), 1.08% (last week), and 1.54% (last month), respectively.

Prudential Bancorp's Stock Yearly Top and Bottom Value

Prudential Bancorp's stock is valued at $14.75 at 13:23 EST, under its 52-week high of $15.95 and way higher than its 52-week low of $11.00.

Prudential Bancorp's Moving Average

Prudential Bancorp's worth is below its 50-day moving average of $14.82 and higher than its 200-day moving average of $14.25.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com